Scope of Agreement NISB will sell the Products as required by MAPU and MAPU agrees to purchase for the price subject to the terms and conditions of the Agreement MAPU estimates its requirement for the current year as follows:
Detection and Diagnostic Kit 500,000 sets Rapid Test Kit 500,000 sets
“MDA approved Novel Coronavirus (2019-nCoV) IgM/IgG Rapid Test Kit samples were sent to Indonesia last week, and today we officially ink the sales. First shipment expected next week,” said Haji Mazru, Executive Director of Nexgram.
“Besides selling the approved Covid-19 test kits, we have sent more product samples (of the Covid-19 test kits) to Medical Device Authority (MDA) under Ministry of Health Malaysia (MoH) for approval. The lab test process is crucial and sourcing more quality product is important looking at shortage of reliable supplies” added Haji Mazru.
Nexgram rapid test kit is approved and selling since early March. I though quietly did not announce Bursa early is breaking Bursa Malaysia rule? Saw many funny MOU also announce everyday. Someone should complain to Bursa.
Indonesia has 230Million total population, which will be new area with highest infection during Ramadan, post Raya.. aiya....chinaman test kit also ok cheaper for mass testing...better than none at all, right? Indon govt. sure will approve it. if just rely on S. Korea kits- where got enough stock? give chinaman kits a chance...sure it improve over time. wakaka
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS STRATEGIC SOURCING AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING MEDICAL DEVICES TO INDONESIA AND CERTAIN PART OF SOUTH EAST ASIA MARKET
NEXGRAM HOLDINGS BERHAD
Type Announcement Subject TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS Description STRATEGIC SOURCING AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING MEDICAL DEVICES TO INDONESIA AND CERTAIN PART OF SOUTH EAST ASIA MARKET The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 16 April 2020 entered into a Strategic Sourcing Agreement (“Agreement”) with PT Mitra Abadi Propertindo Utama (“MAPU”) to sell to MAPU for the latter to promote, market and distribute Detection and Diagnostic Kit and Rapid Test Kit, and other medical supplies products in Indonesia and certain part of South East Asia market, as per the terms and condition of the Agreement.
Please refer to the attachment for details of the announcement.
Nexgram has teamed up with Indonesia’s PT Mitra Abadi Propertindo Utama (MAPU) to sell medical test kits in Indonesia and other Southeast Asian markets.
MAPU has estimated that it will require 500,000 sets of detection and diagnostic kits and 500,000 sets of rapid test kits this year.
Nexgram's test kit is already approved and they are already selling it.
“Besides selling the approved Covid-19 test kits, we have sent more product samples (of the Covid-19 test kits) to Medical Device Authority (MDA) under Ministry of Health Malaysia (MoH) for approval. The lab test process is crucial and sourcing more quality product is important looking at shortage of reliable supplies”
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Monde
1,105 posts
Posted by Monde > 2020-04-20 20:16 | Report Abuse
Scope of Agreement
NISB will sell the Products as required by MAPU and MAPU agrees to purchase for
the price subject to the terms and conditions of the Agreement MAPU estimates its
requirement for the current year as follows:
Detection and Diagnostic Kit
500,000 sets
Rapid Test Kit
500,000 sets